OICHARTS
8 AMThe 8 AM report →

BIIB

Biogen Inc. Common Stock · XNAS · 131 sessions on record
$225.88▼ −1.19 · −0.5%from $227.07 the session before · Sep 30, 2026 close · end of day
Open
$227.23
High
$229.36
Low
$225.51
Day's range
$3.91.7% of the previous close
VWAP
$226.93close −0.46% from it
Volume, shares
1.55M1.56× the 20-session average
Traded, $
$352.5M
Trades
26.5K59 shares per trade
Previous close
$227.07−1.19 to the close
Market cap
$33.35Bat the close of Sep 30
Day range10% of the way up
$225.51$229.36
52-week range93% of the way up
$168.64 Apr 6$230.49 Sep 28

−2.0% from the high · +34% from the low

Options

No listed options on BIIB

Close $ · S&P 500 rebased to the first close126 sessions to Sep 30 · axis fixed at 4 × ATR-14 around the last close
131 sessions on file · from Mar 25
BIIB close over the last 126 sessions, with S&P 500 rebased to the first close172.34209.55246.75axis spans 43%S&P 500BIIBApr 1Jul 2Sep 30126 sessions from Apr 1 to Sep 30; the price axis spans 43 percent.

Quarterly results

consolidated · latest filed Apr 29, 2026 · SEC filings

Revenue $2.48B, +1.9% on a year earlier; profit $319.5M, +33% in the Mar 2026 quarter, consolidated.

Last 8 quarters, consolidatedUS dollars as filed · year on year against the same quarter a year earlier · market: close on the first session after the filing against the last close before it, S&P 500 over the same session
Quarterly results of BIIB on the consolidated basis with the market's move on the first session after each filing
QuarterRevenue $Revenue YoYProfit $Profit YoYEPS $Market on the day
Mar 2026filed Apr 29$2.48B▲ +1.9%$319.5M▲ +33%2.15▼ −2.6%S&P 500 +1.0% · −3.6 pp
Dec 2025filed Feb 6$2.28B▼ −7.1%−$48.9M▼ −120%-0.35—not reached
Sep 2025filed Oct 30$2.53B▲ +2.8%$466.5M▲ +20%3.17—not reached
Jun 2025filed Jul 31$2.65B▲ +7.3%$634.8M▲ +8.8%4.33—not reached
Mar 2025filed Apr 29$2.43B▲ +6.1%$240.5M▼ −39%1.64▼ −2.6%S&P 500 +1.0% · −3.6 pp
Dec 2024filed Feb 12$2.45B▲ +2.9%$266.7M▲ +6.8%1.82—not reached
Sep 2024filed Oct 30$2.47B▼ −2.5%$388.5M—2.66—not reached
Jun 2024filed Jul 31$2.46B▲ +0.36%$583.6M▼ −1.3%4.00—not reached
By fiscal yearfiscal years as filed in the 10-K · named by the year the fiscal year ends
Financial-year results of BIIB on the consolidated basis, summed from the quarters filed
YearRevenue $Revenue YoYProfit $Profit YoYEPS $
FY25to Dec 2025$9.89B▲ +2.2%$1.29B▼ −21%8.79
FY24to Dec 2024$9.68B▼ −1.6%$1.63B▲ +41%11.18
FY23to Dec 2023$9.84B▼ −3.3%$1.16B▼ −62%7.97
FY22to Dec 2022$10.17B▼ −7.4%$3.05B▲ +96%20.87
FY21to Dec 2021$10.98B▼ −18%$1.56B▼ −61%10.40

Fundamentals

consolidated · filings to Mar 2026 · close $225.88 on Sep 30

BIIB trades at 24 times trailing earnings, 2.3 times book value, revenue +1.2% over twelve months, market cap $33.35B.

Valuation
Market cap
$33.35Bon Sep 30
Price to earnings
24consolidated · four quarters to Mar 2026
Trailing EPS
$9.30diluted · consolidated · four quarters to Mar 2026
Price to book
2.3consolidated · balance sheet to Dec 2023
Book value a share
$100.24consolidated · balance sheet to Dec 2023
Debt to equity
0.46borrowings over equity · consolidated · balance sheet to Dec 2023
Return on equity
9.3%trailing profit over average equity · consolidated
Dividend yield
—
Price to sales
3.4market cap over revenue, four quarters to Mar 2026
Shares outstanding
148Mon Sep 30
Growthsums of the four quarters filed to Mar 2026 · growth against the four quarters before them · consolidated
Revenue, trailing 12 months
$9.94Bfour quarters to Mar 2026
Revenue growth, 12 months
▲ +1.2%against the twelve months before
Revenue 3-year CAGR
▼ −0.55%trailing twelve months against the twelve months 3 years earlier · consolidated
Profit, trailing 12 months
$1.37Bfour quarters to Mar 2026
Profit growth, 12 months
▼ −7.3%against the twelve months before
Profit 3-year CAGR
▼ −24%trailing twelve months against the twelve months 3 years earlier · consolidated

Shareholding

quarter to Jun 2026 · SEC Form 13F

13F managers hold 190% of shares, FMR LLC the largest at 25%, BlackRock, Inc. 22% and PRIMECAP MANAGEMENT CO/CA/ 21%, as filed for the quarter to Jun 2026.

Held by 13F managers
190%of shares outstanding
Shares held
278M+5.3% on Mar 2026 among managers filing both
Managers holding
976942 a quarter earlier
Largest holder
25%FMR LLC
Largest 10 holderspercent of shares outstanding · change in shares against the previous quarter
Largest 13F holders of BIIB
ManagerSharesOf outstandingValueChange on quarter
FMR LLC36.4M25%$7.87B+10.8M
BlackRock, Inc.32M22%$6.91B+22.3K
PRIMECAP MANAGEMENT CO/CA/30.3M21%$6.55B+794K
VANGUARD CAPITAL MANAGEMENT LLC19.3M13%$4.17B+227K
STATE STREET CORP14.7M9.9%$3.17B+353K
VANGUARD PORTFOLIO MANAGEMENT LLC13.2M8.9%$2.85B+146K
GEODE CAPITAL MANAGEMENT, LLC8.9M6.0%$1.92B+213K
WELLINGTON MANAGEMENT GROUP LLP6.23M4.2%$1.35B+312K
NORGES BANK5.16M3.5%$1.11B—
MORGAN STANLEY4.82M3.3%$1.04B+481K
Insider tradesSEC Forms 3, 4 and 5 · the latest 10

No open-market insider buying or selling in the last 90 days.

BIIB insider trades
InsiderTradeSharesPriceHeld after
Freire Maria CDirectorgranted · Jun 9, 20262,005$0.008,820
Minor LloydDirectorgranted · Jun 9, 20261,505$0.003,875
Pangalos Menelas NDirectorexercised · Jun 9, 20262,370$0.002,370
Pangalos Menelas NDirectorgranted · Jun 9, 20261,505$0.003,875
Patolawala Monish DDirectorgranted · Jun 9, 20261,505$0.005,215
LANGER SUSANDirectorgranted · Jun 9, 20261,505$0.006,634
Mantas Jesus BDirectorgranted · Jun 9, 20261,505$0.0011,263
Rowinsky Eric KDirectorgranted · Jun 9, 20261,505$0.0025,844
SHERWIN STEPHEN ADirectorgranted · Jun 9, 20261,505$0.0015,193
HAWKINS WILLIAM ADirectorgranted · Jun 9, 20261,505$0.0010,365

Corporate actions

exchange records

No corporate action on record for BIIB yet.

Price history

131 sessions on record · to Sep 30 · end of day

BIIB is +4.5% over 20 sessions against the S&P 500's +0.1%, 2.0% below its 52-week high, realised volatility 26% annualised.

Returns against S&P 500longest window first · S&P 500 over the same sessions
Returns of the stock and S&P 500 over six windows, longest first
WindowFrom $BIIB %S&P 500 %Difference pp
120 sessionssince Apr 9$177.11▲ +28%▲ +12%+15
60 sessionssince Jul 7$205.70▲ +9.8%▲ +2.0%+7.8
20 sessionssince Sep 1$216.05▲ +4.5%▲ +0.11%+4.4
5 sessionssince Sep 23$227.54▼ −0.73%▼ −0.67%−0.06
1 sessionsince Sep 29$227.06▼ −0.52%▼ −0.21%−0.31
Averages of the closeclose against each average
5-session average
$227.12close −0.55% from it
20-session average
$220.77close +2.3% from it
50-session average
$214.41close +5.3% from it
Range and volumetrue range over 14 sessions · high to low over 20 · volume against the 20-session average
Average true range, 14
$5.22.3% of the close
Average day's range, 20
$5.62.5% of the close
Volume against 20 sessions
1.56×1.55M vs 1.03M average
Volatility and co-movement with S&P 500annualised from daily returns
Realised volatility, 20
26%≈ ±1.6% a session · moved more than that on 6 of 20
Realised volatility, 60
35%≈ ±2.2% a session · moved more than that on 16 of 60
Beta to S&P 500, 60
0.29moved with S&P 500 on 43 of 60 sessions
Up and down sessionscloses above and below the previous close
Last 20 sessions
11 up · 9 downof 20
Last 60 sessions
31 up · 29 downof 60
Best session, 250
▲ +7.0%Jun 26
Worst session, 250
▼ −8.2%Jul 14

Biogen Inc. Common Stock is held by

Short-sale volume

25 sessions · to Sep 30, 2026

Short sales were 36% of reported volume on Sep 30, 2026, against 63% over the last 25 sessions.

Last 10 sessionsshare of the day's reported volume
BIIB daily short-sale volume
SessionShort volumeReported volumeShort share
Sep 30, 2026273K763K35.8%
Sep 29, 2026246K471K52.2%
Sep 28, 2026315K502K62.8%
Sep 25, 2026228K301K75.7%
Sep 24, 2026256K374K68.5%
Sep 23, 2026338K487K69.4%
Sep 22, 2026252K402K62.8%
Sep 21, 2026201K334K60.2%
Sep 18, 2026206K282K73.2%
Sep 17, 2026111K246K45.1%

Filings

SEC EDGAR · newest first
BIIB SEC filings
FiledFormReport date
Sep 3, 20264Sep 1, 2026
Aug 12, 20263Aug 3, 2026
Aug 6, 2026SCHEDULE 13G/A—
Aug 5, 20264Aug 3, 2026
Aug 4, 2026144—
Aug 3, 2026144—
Jul 29, 202610-QJun 30, 2026
Jul 29, 20268-KJul 29, 2026
Jul 1, 20268-KJul 1, 2026
Jun 11, 20264Jun 9, 2026
Jun 11, 20264Jun 9, 2026
Jun 11, 20264Jun 9, 2026
Jun 11, 20264Jun 9, 2026
Jun 11, 20264Jun 9, 2026
Jun 11, 20264Jun 9, 2026
Jun 11, 20264Jun 9, 2026
Jun 11, 20264Jun 9, 2026
Jun 11, 20264Jun 9, 2026
Jun 10, 20268-KJun 9, 2026
Jun 10, 20268-K/AMay 14, 2026
Jun 5, 2026SCHEDULE 13G/A—
May 14, 20268-KMay 14, 2026
May 14, 2026SC TO-T/A—
May 14, 2026SCHEDULE 13D/A—
May 12, 2026SC TO-T/A—

About Biogen Inc. Common Stock

SEC and exchange records
Company
Biogen Inc. Common Stock
Exchange
XNAS
SEC CIK
875045
Sessions on record
131
Price source
End of day · delayed
Computed
1 Oct, 10:37 pm IST

OI Charts is not a registered investment adviser or broker-dealer. Prices, filings and open interest are public data and arithmetic on it, not a basis for any investment decision.